Skip to main content
VCbacked
Log inGet Started

Cumulus Neuroscience

Belfast, United Kingdom

Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform.

$4.8M raised
Jul 2025
Venture - Series Unknown
Health CareNeuroscience

Top Investors

Innovate UKDementia Discovery FundLifeArcWhiterock FinanceACF Investors

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Cumulus Neuroscience

How much funding has Cumulus Neuroscience raised?
Cumulus Neuroscience has raised $4.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2025.
Who are Cumulus Neuroscience's investors?
Cumulus Neuroscience's investors include Innovate UK, Dementia Discovery Fund, LifeArc, Whiterock Finance, ACF Investors.
Where is Cumulus Neuroscience headquartered?
Cumulus Neuroscience is headquartered in Belfast, United Kingdom.
What does Cumulus Neuroscience do?
Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform.
What stage is Cumulus Neuroscience at?
Cumulus Neuroscience is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Cumulus Neuroscience — Funding & Investors." VCBacked, July 8, 2025, https://www.vcbacked.co/company/cumulus-neuroscience. Accessed June 4, 2026.
APA
VCBacked. (2025). Cumulus Neuroscience — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/cumulus-neuroscience
Wikipedia (cite web)
{{cite web |title=Cumulus Neuroscience — Funding & Investors |url=https://www.vcbacked.co/company/cumulus-neuroscience |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Virtuoso Surgical
Nashville
Basata
Phoenix
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Sedivention
Munich$848K